Ligand Pharmaceuticals

LGNDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.875 B

$293.15 -2.33%

Close of 7 Aug 2026

Revenue

$268.1M

#2192 by revenue

Earnings

$124.5M

#1217 by earnings

Shares outstanding

19,935,609

Latest filing cover page

P/E ratio

47.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#53Dianthus TherapeuticsDNTH$6.09B
#54Kiniksa Pharmaceuticals InternationalKNSA$5.93B
#55Ligand PharmaceuticalsLGND$5.88B
#56Amneal PharmaceuticalsAMRX$5.79B
#57Travere TherapeuticsTVTX$5.78B

Where these numbers come from

Share counts and financials for Ligand Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.